Trials / Completed
CompletedNCT03177668
Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
Phase I/II Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine tolerability, safety, and pharmacokinetics of YS110 intravenous administration in patients with malignant pleural mesothelioma and to preliminarily examine the anti-tumor effect of YS110.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YS110 | Intravenous administration |
Timeline
- Start date
- 2017-08-08
- Primary completion
- 2020-02-05
- Completion
- 2020-02-05
- First posted
- 2017-06-06
- Last updated
- 2020-09-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03177668. Inclusion in this directory is not an endorsement.